Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study - Paulina

Login with Wikimedia

Login with your Wikimedia account to add/edit data Login

Missing/wrong data? Log in to edit

Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study

scientific article published on 04 June 2018

Author/s

author: Alexander Egle, Franz Josef Gassner, Nadja Zaborsky, Tanja N Hartmann, Lisa Pleyer, Richard Greil

Work details

Publication date

June 4, 2018

Language

English

Copyright status

copyrighted